These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2117205)

  • 1. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome.
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Lung; 1990; 168 Suppl():864-9. PubMed ID: 2117205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
    Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
    Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
    Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
    Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity.
    Holmes JM; Cronin CM; Squires P; Myers TF
    J Pediatr Ophthalmol Strabismus; 1994; 31(3):189-91. PubMed ID: 7931953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].
    Gortner L; Bartmann P; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL; Versmold H
    Z Geburtshilfe Perinatol; 1992; 196(4):159-64. PubMed ID: 1413943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome.
    Schimmel MS; Hammerman C
    Pediatr Radiol; 2000 Oct; 30(10):713-4. PubMed ID: 11075609
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
    J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.